PaxMedica, Inc. (PXMD)
OTCMKTS · Delayed Price · Currency is USD
0.0780
+0.0040 (5.41%)
Dec 20, 2024, 4:00 PM EST

PaxMedica Statistics

Total Valuation

PaxMedica has a market cap or net worth of 878,673. The enterprise value is 554,192.

Market Cap 878,673
Enterprise Value 554,192

Important Dates

The next estimated earnings date is Wednesday, March 12, 2025.

Earnings Date Mar 12, 2025
Ex-Dividend Date n/a

Share Statistics

PaxMedica has 11.31 million shares outstanding. The number of shares has increased by 606.41% in one year.

Current Share Class n/a
Shares Outstanding 11.31M
Shares Change (YoY) +606.41%
Shares Change (QoQ) +3.20%
Owned by Insiders (%) 0.72%
Owned by Institutions (%) 8.07%
Float 10.77M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.03
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.38

Current Ratio 0.38
Quick Ratio 0.15
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -11,794.75

Financial Efficiency

Return on equity (ROE) is -7,716.49% and return on invested capital (ROIC) is -909.14%.

Return on Equity (ROE) -7,716.49%
Return on Assets (ROA) -324.69%
Return on Capital (ROIC) -909.14%
Revenue Per Employee n/a
Profits Per Employee -2.52M
Employee Count 7
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -90.06% in the last 52 weeks. The beta is -0.54, so PaxMedica's price volatility has been lower than the market average.

Beta (5Y) -0.54
52-Week Price Change -90.06%
50-Day Moving Average 0.10
200-Day Moving Average 0.26
Relative Strength Index (RSI) 46.79
Average Volume (20 Days) 44,068

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.03

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -15.44M
Pretax Income -17.66M
Net Income -17.66M
EBITDA n/a
EBIT -15.44M
Earnings Per Share (EPS) -3.51
Full Income Statement

Balance Sheet

Cash & Cash Equivalents 324,486
Total Debt n/a
Net Cash 324,486
Net Cash Per Share 0.03
Equity (Book Value) -1.81M
Book Value Per Share -0.23
Working Capital -1.31M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.32M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

PaxMedica does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -606.41%
Shareholder Yield -606.41%
Earnings Yield -4,520.40%
FCF Yield n/a

Stock Splits

The last stock split was on October 31, 2023. It was a reverse split with a ratio of 0.0588235.

Last Split Date Oct 31, 2023
Split Type Reverse
Split Ratio 0.0588235

Scores

Altman Z-Score n/a
Piotroski F-Score n/a